OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada MORE >>

OPKO Health Completes Enrollment in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes and Obesity MORE >>

OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test MORE >>

OPKO Health Reports First Quarter 2018 Financial Results MORE >>